Intest Res.  2024 Apr;22(2):208-212. 10.5217/ir.2023.00100.

Durability and outcomes of fecal microbiota transplantation for recurrent Clostridioides difficile infection in patients with moderate to severe inflammatory bowel disease

• Tariq R
• Loftus Jr EV
• Pardi D
• Khanna S

• KMID: 2554664
• DOI: http://doi.org/10.5217/ir.2023.00100

Figure

• 

  Fig. 1. (A) Kaplan-Meier survival curve showing proportion of patients with durable response to fecal microbiota transplantation (FMT). (B) Kaplan-Meier survival curve showing proportion of patients with colectomy-free survival. Day 0=date of FMT. CDI, Clostridioides difficile infection.

Reference

1. Ananthakrishnan AN. Clostridium difficile infection: epidemiology, risk factors and management. Nat Rev Gastroenterol Hepatol. 2011; 8:17–26.

2. Khanna S, Shin A, Kelly CP. Management of Clostridium difficile infection in inflammatory bowel disease: expert review from the clinical practice updates Committee of the AGA Institute. Clin Gastroenterol Hepatol. 2017; 15:166–174.

3. Kelly CR, Fischer M, Allegretti JR, et al. ACG clinical guidelines: prevention, diagnosis, and treatment of Clostridioides difficile infections. Am J Gastroenterol. 2021; 116:1124–1147.

4. Tariq R, Pardi DS, Bartlett MG, Khanna S. Low cure rates in controlled trials of fecal microbiota transplantation for recurrent Clostridium difficile infection: a systematic review and meta-analysis. Clin Infect Dis. 2019; 68:1351–1358.

5. Tariq R, Syed T, Yadav D, et al. Outcomes of fecal microbiota transplantation for C. difficile infection in inflammatory bowel disease: a systematic review and meta-analysis. J Clin Gastroenterol. 2023; 57:285–293.

6. Allegretti JR, Kelly CR, Grinspan A, et al. Inflammatory bowel disease outcomes following fecal microbiota transplantation for recurrent C. difficile infection. Inflamm Bowel Dis. 2021; 27:1371–1378.

7. Tariq R, Disbrow MB, Dibaise JK, et al. Efficacy of fecal microbiota transplantation for recurrent C. difficile infection in inflammatory bowel disease. Inflamm Bowel Dis. 2020; 26:1415–1420.

8. Saha S, Mara K, Pardi DS, Khanna S. Durability of response to fecal microbiota transplantation after exposure to risk factors for recurrence in patients with Clostridioides difficile infection. Clin Infect Dis. 2021; 73:e1706–e1712.

9. Tariq R, Weatherly R, Kammer P, Pardi DS, Khanna S. Donor screening experience for fecal microbiota transplantation in patients with recurrent C. difficile infection. J Clin Gastroenterol. 2018; 52:146–150.

10. van Lingen EE, Baunwall SS, Lieberknecht SS, et al. Short- and long-term follow-up after fecal microbiota transplantation as treatment for recurrent Clostridioides difficile infection in patients with inflammatory bowel disease. Therap Adv Gastroenterol. 2023; 16:17562848231156285.